Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Cellebrite DI ( (CLBT) ).
Cellebrite announced the appointment of David Barter as the new Chief Financial Officer, succeeding Dana Gerner who is retiring after 11 years of service. Barter, with extensive experience in scaling global software companies, will oversee financial operations and contribute to Cellebrite’s growth and strategic initiatives, including the recent acquisition of Corellium.
The most recent analyst rating on (CLBT) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Cellebrite DI stock, see the CLBT Stock Forecast page.
Spark’s Take on CLBT Stock
According to Spark, TipRanks’ AI Analyst, CLBT is a Neutral.
Cellebrite DI shows strong revenue growth, operational efficiency, and promising product performance, particularly in ARR and Guardian. However, technical analysis indicates bearish momentum, and the valuation is pressured by a negative P/E ratio. The earnings call provided a positive outlook, but profitability challenges remain a concern.
To see Spark’s full report on CLBT stock, click here.
More about Cellebrite DI
Cellebrite is a global leader in digital investigative solutions, providing AI-powered platforms for public safety organizations, intelligence agencies, and businesses to access, collect, analyze, and share digital evidence. Their solutions are available via cloud, on-premises, and hybrid deployments, focusing on enhancing digital investigations and intelligence gathering to accelerate justice worldwide.
Average Trading Volume: 1,306,049
Technical Sentiment Signal: Buy
Current Market Cap: $3.65B
Learn more about CLBT stock on TipRanks’ Stock Analysis page.